2-((4-Ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2,4,6-tribromophenyl)acetamide

Catalog No. :
ACGHJY141
CAS No. :
578748-95-5
Molecular Formula :
C17H14Br3N5OS
Molecular Weight :
576.11

IUPAC Name:2-((4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2,4,6-tribromophenyl)acetamide

2-((4-Ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2,4,6-tribromophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2,4,6-tribromophenyl)acetamide
IUPAC Name2-((4-ethyl-5-(pyridin-4-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(2,4,6-tribromophenyl)acetamide
MDL No.MFCD04024623
Molecular FormulaC17H14Br3N5OS
Molecular Weight576.11
SMILESO=C(NC1=C(Br)C=C(Br)C=C1Br)CSC2=NN=C(C3=CC=NC=C3)N2CC
InChI KeyBCSTYEMUTYLUAB-UHFFFAOYSA-N
SynonymSALOR-INT L410993-1EA;2-([4-ETHYL-5-(4-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)-N-(2,4,6-TRIBROMOPHENYL)ACETAMIDE
CAS No.578748-95-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGHJY141 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHJY141 route product structure diagram
    ACGHJY141578748-95-5
Inquiry

2. ACGHJY141 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGHJY141 route product structure diagram
    ACGHJY141578748-95-5
Inquiry

Comments (0)